Cancer

Redefining AI Innovation With Social Purpose: Patrick J. McGovern Foundation Announces $73.5 Million Toward AI for Humanity

Foundation Supports 144 Organizations to Champion Human-Centered AI with Capital, AI Expertise, and a Commitment to Inclusive Global AI.BOSTON--(BUSINESS WIRE)--#AIInnovation--Artificial…

1 week ago

March of Dimes Awards Dr. Dennis Lo the 2025 March of Dimes Richard B. Johnston, Jr., MD Prize

Recognized for discovery of cell-free fetal DNA in maternal blood and creation of noninvasive prenatal testing (NIPT), used by as…

1 week ago

Ryght AI Launches Global Clinical Trial Site Network with the University of Southern California as their First Academic Site.

Keck School of Medicine of USC membership will bolster the ranks of academic and community hospitals joining the Ryght Research…

1 week ago

BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up

VANCOUVER, BC, Dec. 17, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company")…

1 week ago

Expert Systems Celebrates Milestone in Clinical Development of Lonitoclax, a Best-in-Class BCL-2 Inhibitor, Developed in Partnership with Lomond Therapeutics

ROCKVILLE, Md., Dec. 17, 2024 /PRNewswire/ -- Expert Systems, a leader in AI-powered drug discovery, proudly celebrates the promising clinical…

1 week ago

Caris Life Sciences Appoints Dr. James Hamrick as Chairman of the Caris Precision Oncology Alliance

IRVING, Texas, Dec. 17, 2024 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine…

1 week ago

FDA Approves Orphan-Drug Designation for Jaguar Health’s Crofelemer for Treatment of Diarrhea in Cholera

World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to…

1 week ago

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the…

1 week ago

Vaccinex Announces Receipt of Delisting Notification from Nasdaq

ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company…

1 week ago

Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

Continued progress with both clinical trials of lead program, SON-1010, for solid tumors and Platinum-Resistant Ovarian Cancer (PROC)  Executed licensing…

1 week ago